Six years into espnW Summit NYC, brands increasingly want in on the gathering of institutional women's sports knowledge. In ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Industry Veteran Brings 30 Years of Experience in Finance, Strategy and Operations WALTHAM, Mass., April 28, 2025 (GLOBE ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

With its 2-star rating, we believe Lilly stock is overvalued compared with our long-term fair value estimate of $650 per ...

Many high-profile lobbyists steered clear of Donald Trump in the days after the Jan. 6, 2021, riot and skipped fundraising ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential.

HSBC analyst warns of a downside in Eli Lilly stock to $700. Rajesh Kumar cited 'valuation' as his number 1 concern.

IBM is making a major bet on America's tech future. The company announced plans on Monday to invest $150 billion across the ...

Top US firms are boosting executive security spending after the killing of UnitedHealth’s Brian Thompson, with costs expected ...

Approved by India’s apex drug regulatory body, the weight-loss drug is a once-weekly injection priced at Rs 4,375 for a 5 mg ...

Mounjaro, the new weight loss drug, is gaining popularity in India for its rapid results. Patients report better appetite control, blood sugar management, and significant weight loss.